Putting night-time dosing of antihypertensives to bed for now

Affiliations

Editorial

Teck K Khong. Drug Ther Bull. 2023 Apr.

. 2023 Apr;61(4):50.

doi: 10.1136/dtb.2022.000069. Epub 2023 Mar 9.

No abstract available

Keywords: Blood pressure; Cardiovascular Diseases; Therapeutics.

Conflict of interest statement

Competing interests: None declared. Refer to the online supplementary files to view the ICMJE form(s).

Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomised, open-label, blinded-endpoint clinical trial.
Mackenzie IS, Rogers A, Poulter NR, Williams B, Brown MJ, Webb DJ, Ford I, Rorie DA, Guthrie G, Grieve JWK, Pigazzani F, Rothwell PM, Young R, McConnachie A, Struthers AD, Lang CC, MacDonald TM; TIME Study Group. Mackenzie IS, et al. Lancet. 2022 Oct 22;400(10361):1417-1425. doi: 10.1016/S0140-6736(22)01786-X. Epub 2022 Oct 11. Lancet. 2022. PMID: 36240838 Free PMC article. Clinical Trial.